0.1 ML Susvimo 100 MG/ML Injection
- RxCUI
- 2584863
- RxNorm name
- 0.1 ML Susvimo 100 MG/ML Injection
- Display name
- 0.1 ML Susvimo 100 MG/ML Injection
- Full name
- 0.1 ML Susvimo 100 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761197 | Susvimo | ranibizumab | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Susvimo | RANIBIZUMAB | Genentech, Inc. | 9c6d9e2a-9a77-4d11-b692-de87cfde3444 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 2584863 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9c6d9e2a-9a77-4d11-b692-de87cfde3444 | Susvimo 10 MG in 0.1 ML Injection [PSN] · 0.1 ML ranibizumab 100 MG/ML Injection [Susvimo] [SBD] · 0.1 ML Susvimo 100 MG/ML Injection [SY] · Susvimo 10 MG per 0.1 ML Injection [SY] | 4 | 14 | These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO ® (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 2006 | 20251121 |